U.S. markets close in 55 minutes

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
82.11-2.14 (-2.54%)
As of 3:05PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close84.25
Open84.25
Bid82.18 x 800
Ask82.24 x 800
Day's Range81.25 - 84.85
52 Week Range51.51 - 92.08
Volume1,800,471
Avg. Volume2,533,860
Market Cap51.279B
Beta (5Y Monthly)1.02
PE Ratio (TTM)63.16
EPS (TTM)1.30
Earnings DateApr 21, 2021 - Apr 26, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est94.25
  • Tighten Your Sell Stops on Edwards Lifesciences
    TheStreet.com

    Tighten Your Sell Stops on Edwards Lifesciences

    Prices have yet to reach our $104 price target and remain above $79 but we still want to check the charts again. In this updated daily bar chart of EW, below, we can see that prices have been in a choppy sideways pattern since September. The On-Balance-Volume (OBV) line has been declining since the beginning of 2021 and tells us that sellers of EW have been more aggressive.

  • Many Would Be Jealous Of Edwards Lifesciences' (NYSE:EW) Returns On Capital
    Simply Wall St.

    Many Would Be Jealous Of Edwards Lifesciences' (NYSE:EW) Returns On Capital

    To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'll want to...

  • Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years
    PR Newswire

    Edwards RESILIA Tissue Aortic Valve Demonstrates Favorable Safety and Efficacy at Five Years

    Edwards Lifesciences (NYSE: EW) today announced new data from the COMMENCE clinical trial that demonstrate Edwards' bioprosthetic surgical aortic valve with the company's novel RESILIA tissue platform show favorable safety and hemodynamic performance through a median of five years follow-up. The data were presented at the 57th annual meeting of the Society of Thoracic Surgeons.